US Broker Ratings

Dyne Therapeutics, Inc. (DYN) Stock Analysis: A Biotech Contender with a 108% Upside Potential

Dyne Therapeutics, Inc. (NASDAQ: DYN) has garnered significant attention in the biotechnology sector, offering a compelling opportunity for investors willing to navigate the high-risk, high-reward landscape..

CG Oncology, Inc. (CGON) Stock Analysis: Biotechnology Innovator with a 45.78% Potential Upside

CG Oncology, Inc. (NASDAQ: CGON) is making waves in the biotechnology sector with its promising pipeline of therapeutics aimed at tackling bladder cancer. With a market..

UFP Technologies, Inc. (UFPT) Stock Analysis: Healthcare Innovator with 28.78% Potential Upside

Investors keeping an eye on the medical devices sector may find UFP Technologies, Inc. (UFPT) to be an intriguing opportunity. With a market capitalization of $1.97..

Adaptive Biotechnologies (ADPT) Stock Analysis: Investor Outlook on a Healthcare Innovator with 102% Revenue Growth

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands out in the biotechnology sector, not just for its innovative approach to immune medicine but also for its remarkable revenue..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Is a 100% Upside Within Reach?

GoodRx Holdings, Inc. (NASDAQ: GDRX) stands as a fascinating player in the healthcare sector, specializing in health information services within the United States. With a market..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A 69% Upside Potential in the Biotech Arena

Beam Therapeutics Inc. (NASDAQ: BEAM) stands as a compelling player in the biotechnology sector, with a market capitalization of $2.83 billion. Headquartered in Cambridge, Massachusetts, Beam..

Organon & Co. (OGN) Stock Analysis: Evaluating Healthcare’s Undervalued Opportunity with a 14% Upside

Organon & Co. (NYSE: OGN), a notable player in the healthcare sector, is attracting attention from investors with its diverse portfolio of prescription therapies and medical..

Phreesia, Inc. (PHR): Investor Outlook with 116.74% Potential Upside

Phreesia, Inc. (PHR) is making waves in the healthcare sector with its innovative SaaS-based solutions, offering a robust platform for patient intake and payment services. Based..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 29% Potential Upside in the Medical Devices Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the medical devices industry, is capturing investor attention with a notable potential upside of 29.18%. Headquartered..

LifeStance Health Group, Inc. (LFST): Analyst Consensus Points to 23.8% Upside Potential

Investors eyeing the healthcare sector might find LifeStance Health Group, Inc. (LFST) an intriguing option, given the company’s promising upside potential and its focus on expanding..

Disc Medicine, Inc. (IRON) Investor Outlook: Unveiling a 51% Potential Upside in the Biotech Sector

Disc Medicine, Inc. (NASDAQ: IRON), a promising name in the biotechnology sector, is capturing investor attention with its substantial 51.37% potential upside. This clinical-stage biopharmaceutical company,..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring a 57% Potential Upside for Investors

Investors with a keen eye on the biotechnology sector might find Centessa Pharmaceuticals plc (NASDAQ: CNTA) an intriguing proposition. With a substantial market capitalization of $3.72..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 20% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a key player in the healthcare sector specializing in medical instruments and supplies, is drawing investor attention with its promising growth..

Premier, Inc. (PINC) Stock Analysis: Navigating a Flat Landscape with 2.97% Dividend Yield

Premier, Inc. (NASDAQ: PINC), a key player in the healthcare sector, operates primarily in the health information services industry. With a market cap of $2.34 billion,..

SS Innovations International (SSII) Stock Analysis: Exploring the 192.50% Revenue Growth in the Healthcare Sector

SS Innovations International, Inc. (SSII), a key player in the medical devices industry, is making waves with its substantial 192.50% revenue growth. Headquartered in Gurugram, India,..

Galapagos NV (GLPG) Stock Analysis: A High-Stakes Bet in Biotechnology with an 18.9% Revenue Growth

Galapagos NV (GLPG), a Belgian biotechnology powerhouse, is an intriguing player in the healthcare sector. With a market capitalization of $2.26 billion, Galapagos continues to draw..

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a Potential 92.5% Upside

Investors with an eye on the biotechnology sector may find ImmunityBio, Inc. (NASDAQ: IBRX) an intriguing prospect. With its current market cap standing at $6.04 billion..

IDEAYA Biosciences (IDYA): Unpacking the 46.63% Potential Upside in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA) is gaining notable attention in the biotechnology sector, offering a promising proposition for investors keen on the precision oncology market. With..

Certara, Inc. (CERT) Investor Outlook: Evaluating a 49% Potential Upside in Health Information Services

Certara, Inc. (NASDAQ: CERT) is drawing attention in the healthcare sector, particularly in the health information services industry, where it operates as a key player providing..

PROCEPT BioRobotics (PRCT) Stock Analysis: A 74% Potential Upside in the Medical Robotics Field

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is making waves in the healthcare sector, specifically within the medical devices industry. The company’s focus on developing transformative solutions in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds